Curi RMB Capital’s Impax Laboratories, Inc. IPXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-103,631
Closed -$2.02M 1009
2018
Q1
$2.02M Sell
103,631
-24,099
-19% -$473K 0.05% 386
2017
Q4
$2.13M Buy
+127,730
New +$2.34M 0.06% 365

Curi RMB Capital's IPXL Position: Q2 2018 in Review

Curi RMB Capital sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 103,631 shares — an estimated $2.02M sold.

Curi RMB Capital first reported a position in IPXL in Q4 2017 and held it in 2 quarters. The position peaked at $2.13M in Q4 2017. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.

  • Curi RMB Capital reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
  • Curi RMB Capital sold 103,631 Impax Laboratories, Inc. shares in Q2 2018, an estimated $2.02M.
  • Curi RMB Capital first reported a position in Impax Laboratories, Inc. in Q4 2017 and held it in 2 quarters.
  • Curi RMB Capital's Impax Laboratories, Inc. position peaked at $2.13M in Q4 2017.
  • 1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.

Based on Curi RMB Capital's 13F filing for Q2 2018, filed 13 Aug 2018.